Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELIQUIS vs ELTROMBOPAG OLAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELIQUIS vs ELTROMBOPAG OLAMINE: Safety Overview

Metric ELIQUIS ELTROMBOPAG OLAMINE
Total FAERS Reports 1,430 16,074
Deaths Reported 98 3,457
Death Rate 6.9% 21.5%
Hospitalizations 273 3,284
Average Patient Age 76.5 yrs 56.5 yrs
% Female Patients 100.0% 57.7%
FDA Approval Date N/A Apr 18, 2024
Manufacturer N/A XLCare Pharmaceuticals Inc.
Route N/A ORAL
Marketing Status N/A Prescription